Colonia, NJ, United States of America

Chander Shekher Celly

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Intervet Inc., Schering Corporation, Schering-Plough Animal Health Corporation. Active years: 2009-2014.

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chander Shekher Celly: Innovator in Pharmaceutical Chemistry

Introduction

Chander Shekher Celly is a notable inventor based in Colonia, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on developing novel compounds with therapeutic applications.

Latest Patents

Celly's latest patents include innovative compounds such as substituted piperazines as CB1 antagonists, which are designed to target specific receptors in the body. Additionally, he has developed carbonates of fenicol antibiotics, which are novel fenicol compounds that possess useful properties as antibiotic prodrugs. These patents not only highlight his inventive capabilities but also showcase methods for making and utilizing these new compounds effectively.

Career Highlights

Throughout his career, Celly has worked with prominent companies in the pharmaceutical industry, including Intervet Inc. and Schering Corporation. His experience in these organizations has allowed him to refine his skills and contribute to various projects that advance medical science.

Collaborations

Celly has collaborated with esteemed colleagues such as Eric J. Gilbert and Michael W. Miller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Chander Shekher Celly is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic compounds. His contributions continue to impact the field positively, and his patents reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…